These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats. Ciosek J; Cisowska A J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616 [TBL] [Abstract][Full Text] [Related]
10. Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt loaded rats. Cisowska-Maciejewska A; Ciosek J J Physiol Pharmacol; 2005 Dec; 56(4):673-88. PubMed ID: 16391423 [TBL] [Abstract][Full Text] [Related]
11. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin. Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats. de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207 [TBL] [Abstract][Full Text] [Related]
13. Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress. Rabasa C; Pastor-Ciurana J; Delgado-Morales R; Gómez-Román A; Carrasco J; Gagliano H; García-Gutiérrez MS; Manzanares J; Armario A Eur Neuropsychopharmacol; 2015 Aug; 25(8):1248-59. PubMed ID: 26092203 [TBL] [Abstract][Full Text] [Related]
14. Vasopressin and oxytocin release and the thyroid function. Ciosek J; Drobnik J J Physiol Pharmacol; 2004 Jun; 55(2):423-41. PubMed ID: 15213363 [TBL] [Abstract][Full Text] [Related]
15. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Zoppi S; Pérez Nievas BG; Madrigal JL; Manzanares J; Leza JC; García-Bueno B Neuropsychopharmacology; 2011 Mar; 36(4):805-18. PubMed ID: 21150911 [TBL] [Abstract][Full Text] [Related]
16. CB(1) modulation of hormone secretion, neuronal activation and mRNA expression following extracellular volume expansion. Ruginsk SG; Uchoa ET; Elias LL; Antunes-Rodrigues J Exp Neurol; 2010 Jul; 224(1):114-22. PubMed ID: 20214896 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress. Derks NM; Pintér O; Zuure W; Ledent C; Watanabe M; Molnár CS; Wei Y; Roubos EW; Wu S; Hrabovszky E; Zelena D; Kozicz T J Neuroendocrinol; 2012 Nov; 24(11):1447-61. PubMed ID: 22734681 [TBL] [Abstract][Full Text] [Related]
18. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis. Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779 [TBL] [Abstract][Full Text] [Related]
20. Activation of PAR1 in the lateral hypothalamus of rats enhances food intake and REMS through CB1R. Pérez-Morales M; Alvarado-Capuleño I; López-Colomé AM; Méndez-Díaz M; Ruiz-Contreras AE; Prospéro-García O Neuroreport; 2012 Oct; 23(14):814-8. PubMed ID: 22889888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]